Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia.

BACKGROUND & AIMS Transgenic FVB/N insulin-gastrin (INS-GAS) mice have high circulating gastrin levels, and develop spontaneous atrophic gastritis and gastrointestinal intraepithelial neoplasia (GIN) with 80% prevalence 6 months after Helicobacter pylori infection. GIN is associated with gastric atrophy and achlorhydria, predisposing mice to nonhelicobacter microbiota overgrowth. We determined if germfree INS-GAS mice spontaneously develop GIN and if H pylori accelerates GIN in gnotobiotic INS-GAS mice. METHODS We compared gastric lesions, levels of messenger RNA, serum inflammatory mediators, antibodies, and gastrin among germfree and H pylori-monoinfected INS-GAS mice. Microbiota composition of specific pathogen-free (SPF) INS-GAS mice was quantified by pyrosequencing. RESULTS Germfree INS-GAS mice had mild hypergastrinemia but did not develop significant gastric lesions until 9 months old and did not develop GIN through 13 months. H pylori monoassociation caused progressive gastritis, epithelial defects, oxyntic atrophy, marked foveolar hyperplasia, dysplasia, and robust serum and tissue proinflammatory immune responses (particularly males) between 5 and 11 months postinfection (P<0.05, compared with germfree controls). Only 2 of 26 female, whereas 8 of 18 male, H pylori-infected INS-GAS mice developed low to high-grade GIN by 11 months postinfection. Stomachs of H pylori-infected SPF male mice had significant reductions in Bacteroidetes and significant increases in Firmicutes. CONCLUSIONS Gastric lesions take 13 months longer to develop in germfree INS-GAS mice than male SPF INS-GAS mice. H pylori monoassociation accelerated gastritis and GIN but caused less severe gastric lesions and delayed onset of GIN compared with H pylori-infected INS-GAS mice with complex gastric microbiota. Changes in gastric microbiota composition might promote GIN in achlorhydric stomachs of SPF mice.

[1]  J. Chun,et al.  The analysis of oral microbial communities of wild-type and toll-like receptor 2-deficient mice using a 454 GS FLX Titanium pyrosequencer , 2010, BMC Microbiology.

[2]  Mark J. Miller,et al.  Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. , 2010, Gastroenterology.

[3]  R. Lechler,et al.  Helicobacter pylori Stimulates Dendritic Cells To Induce Interleukin-17 Expression from CD4+ T Lymphocytes , 2009, Infection and Immunity.

[4]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[5]  Sm,et al.  and Gastric Cancer , 2009 .

[6]  T. Wang,et al.  Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. , 2009, Cancer research.

[7]  David J Van Horn,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[8]  T. Wang,et al.  Gastrin is an essential cofactor for helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice. , 2009, The American journal of pathology.

[9]  K. Tominaga,et al.  Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. , 2009, Biochemical and biophysical research communications.

[10]  Mathilda Lindberg,et al.  Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. , 2009, Journal of Medical Microbiology.

[11]  Y. Yamaoka,et al.  IL‐17 is Involved in Helicobacter pylori‐Induced Gastric Inflammatory Responses in a Mouse Model , 2008, Helicobacter.

[12]  D. Rifkin,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[13]  H. Maaroos,et al.  Epidemiology of Helicobacter pylori Infection , 2008, Helicobacter.

[14]  T. Wang,et al.  Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. , 2008, Cancer research.

[15]  T. Wang,et al.  W1090 Combination of Sulindac and H. pylori Eradication Prevents Progression of Gastric Cancer in Hypergastrinemic Ins-Gas Mice , 2008 .

[16]  T. Wang,et al.  Protective role of 17 beta -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. , 2007, Carcinogenesis.

[17]  H. Petty,et al.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. , 2007, Experimental eye research.

[18]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[19]  K. McCoy,et al.  Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. , 2007, Seminars in immunology.

[20]  J. Fox,et al.  Wild-Type and Interleukin-10-Deficient Regulatory T Cells Reduce Effector T-Cell-Mediated Gastroduodenitis in Rag2−/− Mice, but Only Wild-Type Regulatory T Cells Suppress Helicobacter pylori Gastritis , 2007, Infection and Immunity.

[21]  T. Wang,et al.  Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.

[22]  T. Tsukamoto,et al.  High salt diets dose‐dependently promote gastric chemical carcinogenesis in Helicobacter pylori‐infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells , 2006, International journal of cancer.

[23]  M. Oda,et al.  Non-Helicobacter Bacterial Flora Rarely Develops in the Gastric Mucosal Layer of Children , 2006, Digestive Diseases and Sciences.

[24]  U. Göbel,et al.  Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. , 2006, FEMS immunology and medical microbiology.

[25]  E. Purdom,et al.  Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Timothy C Wang,et al.  Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. , 2005, Cancer research.

[27]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[28]  L. Bravo,et al.  Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[29]  James R. Cole,et al.  The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis , 2004, Nucleic Acids Res..

[30]  H. Brenner,et al.  Epidemiology of Helicobacter pylori Infection , 2004, Helicobacter.

[31]  J. Fox,et al.  Spatial Distribution and Stability of the Eight Microbial Species of the Altered Schaedler Flora in the Mouse Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.

[32]  J. Gordon,et al.  Gnotobiotic transgenic mice reveal that transmission of Helicobacter pylori is facilitated by loss of acid-producing parietal cells in donors and recipients. , 2004, Microbes and infection.

[33]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[34]  R. Peek,et al.  Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. , 2003, Gastroenterology.

[35]  T. Wang,et al.  Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. , 2003, Cancer research.

[36]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[37]  G. Rieder,et al.  Gastritis and Hypergastrinemia Due to Acinetobacter lwoffii in Mice , 2002, Infection and Immunity.

[38]  D. Jonkers,et al.  Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[39]  D. Jonkers,et al.  Non‐Helicobacter pylori bacterial flora during acid‐suppressive therapy: differential findings in gastric juice and gastric mucosa , 2001, Alimentary pharmacology & therapeutics.

[40]  C. Mowat,et al.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.

[41]  M. Blaser,et al.  Theoretical and experimental approaches for studying factors defining the Helicobacter pylori-host relationship. , 2000, Trends in microbiology.

[42]  Mark T. Whary,et al.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy , 2000, Nature Medicine.

[43]  C. Nord,et al.  Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[44]  F. Dewhirst,et al.  Phylogeny of the Defined Murine Microbiota: Altered Schaedler Flora , 1999, Applied and Environmental Microbiology.

[45]  S. Kamiya,et al.  Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. , 1997, Gut.

[46]  C. Nord,et al.  Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. , 1996, The Journal of antimicrobial chemotherapy.

[47]  T. Wang,et al.  Processing and proliferative effects of human progastrin in transgenic mice. , 1996, The Journal of clinical investigation.

[48]  J. Gordon,et al.  Diphtheria Toxin-mediated Ablation of Parietal Cells in the Stomach of Transgenic Mice (*) , 1996, The Journal of Biological Chemistry.

[49]  H. Robin,et al.  Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results , 1994, Journal of clinical microbiology.

[50]  E. Schmidt,et al.  Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. , 1993, The Journal of clinical investigation.

[51]  J. Fox,et al.  Helicobacter felis gastritis in gnotobiotic rats: an animal model of Helicobacter pylori gastritis , 1991, Infection and immunity.

[52]  J. Fox,et al.  A small animal model of human Helicobacter pylori active chronic gastritis. , 1990, Gastroenterology.

[53]  Hermann Brenner,et al.  Epidemiology of stomach cancer. , 2009, Methods in molecular biology.

[54]  R. D. Wagner,et al.  Effects of microbiota on GI health: gnotobiotic research. , 2008, Advances in experimental medicine and biology.

[55]  P. Sipponen,et al.  Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis , 2002, Gastric Cancer.

[56]  G. Rieder,et al.  Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice. , 2002, Gastroenterology.

[57]  T. Wang,et al.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. , 2000, Gastroenterology.

[58]  T. Wang,et al.  Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. , 1996, Gastroenterology.